The Victorian Government has expanded the High Production Freight Vehicle (HPFV) network, improving freight connections across the State and promoting the use of safer and cleaner vehicles.
In another milestone for Victoria’s world class tertiary sector, La Trobe University has entered a strategic partnership with India to improve data protection policy practices across different industry’s supply chains.
The first Australian batch of a COVID-19 mRNA vaccine will be manufactured in Victoria for clinical trials, using a vaccine candidate developed by Victorian researchers.
A global logistics company is set to invest $147 million to expand its Asia Pacific headquarters in Melbourne, in a move which will strengthen Victoria’s position as a market of choice for businesses in the food and fibre, transport, distribution and logistics industries.
A newly established Scientific Advisory Group will bring together leading local and global vaccine experts, including an award-winning immunologist and virologist, to provide advice on mRNA manufacturing capability in Victoria.
In an exciting development for Victoria’s world leading medical research sector, Hudson Institute is now home to new cutting edge technology that will provide unprecedented genomic capacity to study inflammatory diseases and microbial diversity.
A global health technology and caregiving startup from Singapore has picked Melbourne for its Australian headquarters, further strengthening the State’s thriving world class health technology sector.
Swinburne University of Technology will partner with metal additive manufacturing specialist Amaero International to undertake a project on coatings for space vehicle components – another great collaboration between the tertiary and private sectors.
Monash University has signed a Memorandum of Understanding (MoU) with global energy company ENGIE, building on the strong track record of collaborations between the tertiary and private sectors.
Australia’s national science agency, the CSIRO, has launched a Hydrogen Industry Mission to accelerate key projects and boost research collaborations to help grow the sector.
A new dedicated organisation charged with building Victoria’s mRNA manufacturing capability has been established, putting the State at the forefront of developing life-saving vaccines and therapeutic treatments for all Australians.
Applications are now open for low-interest loans to help innovative Victorian small to medium enterprises (SMEs) continue developing new products, services and technologies vital to the State’s future economy.